Journal articles on the topic 'DTA'

Branda, F., A. Marotta, and A. Buri. "Nucleation kinetic data from DTA curves." Thermochimica Acta 135 (October 1988): 91–96. http://dx.doi.org/10.1016/0040-6031(88)87371-4.

Podoba, Rudolf, and Ľuboš Podobník. "Upgrading of TGA/DTA analyzer derivatograph." Epitoanyag - Journal of Silicate Based and Composite Materials 64, no. 1-2 (2012): 28–29. http://dx.doi.org/10.14382/epitoanyag-jsbcm.2012.5.

Fǎtu, D. "Plotting of phase diagrams from DTA data." Thermochimica Acta 92 (September 1985): 57–60. http://dx.doi.org/10.1016/0040-6031(85)85816-0.

Hatakeyama, Tatsuko. "DSC,DTA,TG." Kobunshi 40, no. 4 (1991): 264–67. http://dx.doi.org/10.1295/kobunshi.40.264.

Jorda, J. L. "DTA/TG coupling." Journal of Thermal Analysis 48, no. 3 (March 1997): 585–96. http://dx.doi.org/10.1007/bf01979505.

Cawley, Adam. "Non‐targeted screening of drugs." Drug Testing and Analysis 13, no. 5 (May 2021): 892–93. http://dx.doi.org/10.1002/dta.3053.

Sobolevsky, Tim, and Brian Ahrens. "Measurement of urinary cobalt as its complex with 2‐(5‐chloro‐2‐pyridylazo)‐5‐diethylaminophenol by liquid chromatography–tandem mass spectrometry for the purpose of anti‐doping control." Drug Testing and Analysis 13, no. 6 (January 27, 2021): 1145–57. http://dx.doi.org/10.1002/dta.3004.

Al‐Zahrani, Mansour A., Ahmed I. Al‐Asmari, Farouq F. Al‐Zahrani, Hazel J. Torrance, and David G. Watson. "Quantification of cannabinoids in human hair using a modified derivatization procedure and liquid chromatography–tandem mass spectrometry." Drug Testing and Analysis 13, no. 6 (February 16, 2021): 1095–107. http://dx.doi.org/10.1002/dta.3005.

Barnabé, Agnès, Yves Moulard, Stephane Trevisiol, Sophie Boyer, Mylène Caroff, Wafek Taleb, Sophie Tendon, et al. "Kavain detection in post‐race equine urine sample: A case report." Drug Testing and Analysis 13, no. 4 (January 26, 2021): 883–86. http://dx.doi.org/10.1002/dta.2996.

Moreira, Fernando, Helena Carmo, Paula Guedes de Pinho, and Maria de Lourdes Bastos. "Doping detection in animals: A review of analytical methodologies published from 1990 to 2019." Drug Testing and Analysis 13, no. 3 (February 2021): 474–504. http://dx.doi.org/10.1002/dta.2999.

Wiedfeld, Christopher, Gisela Skopp, and Frank Musshoff. "Single hair analysis: Validation of a screening method for over 150 analytes and application on documented single‐dose cases." Drug Testing and Analysis 13, no. 4 (January 15, 2021): 817–32. http://dx.doi.org/10.1002/dta.2997.

Odoardi, Sara, Serena Mestria, Giulia Biosa, Raffaella Arfè, Micaela Tirri, Matteo Marti, and Sabina Strano Rossi. "Metabolism study and toxicological determination of mephtetramine in biological samples by liquid chromatography coupled with high‐resolution mass spectrometry." Drug Testing and Analysis 13, no. 8 (May 4, 2021): 1516–26. http://dx.doi.org/10.1002/dta.3044.

Koh, Andy Hsien Wei, Russ Chess‐Williams, and Anna Elizabeth Lohning. "Racemic synephrine found in Citrus aurantium ‐listing pre‐workout supplements suggests a non‐plant‐based origin." Drug Testing and Analysis 13, no. 8 (April 16, 2021): 1569–75. http://dx.doi.org/10.1002/dta.3042.

Stove, Christophe. "Obituary Peter Blanckaert." Drug Testing and Analysis 13, no. 7 (April 13, 2021): 1464–65. http://dx.doi.org/10.1002/dta.3039.

Lund, Rachel A., Elliot R. Cooper, Hui Wang, Zoe Ashley, Adam T. Cawley, and Alison K. Heather. "Nontargeted detection of designer androgens: Underestimated role of in vitro bioassays." Drug Testing and Analysis 13, no. 5 (May 2021): 894–902. http://dx.doi.org/10.1002/dta.3049.

Schulze, Jenny, Kim Pettersson‐Bohlin, John‐Olof Thörngren, and Lena Ekström. "Re‐evaluation of combined ((ES/EG)/(TS/TG)) ratio as a marker of testosterone intake in men." Drug Testing and Analysis 13, no. 8 (April 22, 2021): 1576–79. http://dx.doi.org/10.1002/dta.3045.

Paul, Richard, Steve Smith, Luke Gent, and Ryan Sutherill. "Air monitoring for synthetic cannabinoids in a UK prison: Application of personal air sampling and fixed sequential sampling with thermal desorption two‐dimensional gas chromatography coupled to time‐of‐flight mass spectrometry." Drug Testing and Analysis 13, no. 9 (May 26, 2021): 1678–85. http://dx.doi.org/10.1002/dta.3101.

Dunn, Keeley, Amelia Taylor, and Sophie Turfus. "A review of cannabidiol‐containing electronic liquids—Current regulations and labelling accuracy." Drug Testing and Analysis 13, no. 8 (June 2, 2021): 1490–98. http://dx.doi.org/10.1002/dta.3102.

Shao, Xue‐Ting, Han Yu, Jian‐Guo Lin, Xiang‐Peng Kong, Zhuang Wang, and De‐Gao Wang. "Presence of the ketamine analog of 2‐fluorodeschloroketamine residues in wastewater." Drug Testing and Analysis 13, no. 9 (May 25, 2021): 1650–57. http://dx.doi.org/10.1002/dta.3098.

Kintz, Pascal, Laurie Gheddar, Alice Ameline, and Jean‐Sébastien Raul. "Hair testing for acetazolamide as an evidence of the use of a contaminated dietary supplement." Drug Testing and Analysis 13, no. 8 (May 28, 2021): 1584–88. http://dx.doi.org/10.1002/dta.3100.

Mariottini, Claudia, Merja Gergov, and Ilkka Ojanperä. "Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography–tandem mass spectrometry." Drug Testing and Analysis 13, no. 9 (June 3, 2021): 1658–67. http://dx.doi.org/10.1002/dta.3104.

Bardhi, Anisa, Anna Zaghini, Olivier Levionnois, and Andrea Barbarossa. "A quick approach for medetomidine enantiomer determination in dog plasma by chiral liquid chromatography–tandem mass spectrometry and application to a pharmacokinetic study." Drug Testing and Analysis 13, no. 7 (February 23, 2021): 1249–55. http://dx.doi.org/10.1002/dta.3015.

Mathew, Binoy, Moses Philip, Zubair Perwad, Tajudheen K. Karatt, Marina Rodriguez Caveney, Michael Benedict Subhahar, and Abdul Khader Karakka Kal. "Identification of Hypoxia‐inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control." Drug Testing and Analysis 13, no. 6 (February 23, 2021): 1203–15. http://dx.doi.org/10.1002/dta.3014.

Mongongu, Cynthia, François Coudoré, Valérie Domergue, Magnus Ericsson, Corinne Buisson, and Alexandre Marchand. "Detection of LongR 3 ‐IGF‐I, Des(1‐3)‐IGF‐I, and R 3 ‐IGF‐I using immunopurification and high resolution mass spectrometry for antidoping purposes." Drug Testing and Analysis 13, no. 7 (February 22, 2021): 1256–69. http://dx.doi.org/10.1002/dta.3016.

Savill, Ryan, Helge Baues, Emmely Voigt, Oliver Zierau, Detlef Thieme, and Annekathrin Martina Keiler. "Cell culture as a toolbox to generate phase I metabolites for antidoping screening." Drug Testing and Analysis 13, no. 6 (February 11, 2021): 1169–77. http://dx.doi.org/10.1002/dta.3009.

Favro, Gianna, Hadi Habib, Ingrid Gennity, Birgit Puschner, Erin N. Hales, Carrie J. Finno, and Benjamin C. Moeller. "Determination of vitamin E and its metabolites in equine urine using liquid chromatography–mass spectrometry." Drug Testing and Analysis 13, no. 6 (February 9, 2021): 1158–68. http://dx.doi.org/10.1002/dta.3006.

Ye, Yongbin, Xiaojuan Guo, Xin He, Mingwan Zhang, Huiqing He, Dafa Qiu, and Ziwen Guo. "High‐resolution mass spectrometry‐based approach for the identification and profiling of the metabolites of taletrectinib formed in liver microsomes." Drug Testing and Analysis 13, no. 6 (February 8, 2021): 1118–26. http://dx.doi.org/10.1002/dta.3008.

Mikhail, Ezra, Erik Siccardi, Ali Bawazir, Ambika Rajesh, Seetharani Prathyush, Duaa Mohammad Kamal Al Wazani, Muhammed Sabeek, and Thomas John. "A validated method for the quantification of IOX‐2, a potent prolyl hydroxylase inhibitor in equine urine and plasma using liquid chromatography–high‐resolution mass spectrometry." Drug Testing and Analysis 13, no. 6 (February 6, 2021): 1178–90. http://dx.doi.org/10.1002/dta.3010.

Larabi, Islam Amine, Fanny Zerizer, Alice Ameline, Isabelle Etting, Delphine Joseph, Pascal Kintz, and Jean Claude Alvarez. "Metabolic profiling of deschloro‐ N ‐ethyl‐ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high‐resolution accurate mass spectrometry." Drug Testing and Analysis 13, no. 6 (February 12, 2021): 1108–17. http://dx.doi.org/10.1002/dta.3007.

Thevis, Mario, Tiia Kuuranne, Andreas Thomas, and Hans Geyer. "Do dried blood spots have the potential to support result management processes in routine sports drug testing?—Part 2: Proactive sampling for follow‐up investigations concerning atypical or adverse analytical findings." Drug Testing and Analysis 13, no. 3 (February 11, 2021): 505–9. http://dx.doi.org/10.1002/dta.3011.

Trevisiol, Stéphane, Yves Moulard, Vivian Delcourt, Murielle Jaubert, Sophie Boyer, Sophie Tendon, Hayate Haryouli, et al. "Comprehensive characterization of the peroxisome proliferator activated receptor‐δ agonist GW501516 for horse doping control analysis." Drug Testing and Analysis 13, no. 6 (February 11, 2021): 1191–202. http://dx.doi.org/10.1002/dta.3013.

Jeppesen, Jan Sommer, Andreas Breenfeldt Andersen, Thomas Christian Bonne, Martin Thomassen, Helle Sørensen, Nikolai Baastrup Nordsborg, Niels Vidiendal Olsen, Jesús Rodríguez Huertas, and Jacob Bejder. "Immature reticulocytes are sensitive and specific to low‐dose erythropoietin treatment at sea level and altitude." Drug Testing and Analysis 13, no. 7 (March 29, 2021): 1331–40. http://dx.doi.org/10.1002/dta.3031.

Okochi, Hideaki, Alexander Louie, Nhi Phung, Kevin Zhang, Regina M. Tallerico, Karen Kuncze, Matthew A. Spinelli, Catherine A. Koss, Leslie Z. Benet, and Monica Gandhi. "Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide‐based ART." Drug Testing and Analysis 13, no. 7 (April 13, 2021): 1354–70. http://dx.doi.org/10.1002/dta.3033.

Concheiro, Marta, Frank Martin Gutierrez, Alejandro Ocampo, Elena Lendoiro, Eva González‐Colmenero, Ana Concheiro‐Guisán, Patricia Peñas‐Silva, et al. "Assessment of biological matrices for the detection of in utero cannabis exposure." Drug Testing and Analysis 13, no. 7 (June 23, 2021): 1371–82. http://dx.doi.org/10.1002/dta.3034.

Kraiem, Souhail, Maneera Y. Al‐Jaber, Hana Al‐Mohammed, Afnan S. Al‐Menhali, Noora Al‐Thani, Murad Helaleh, Waseem Samsam, et al. "Analytical strategy for the detection of ecdysterone and its metabolites in vivo in uPA(+/+)‐SCID mice with humanized liver, human urine samples, and estimation of prevalence of its use in anti‐doping samples." Drug Testing and Analysis 13, no. 7 (May 4, 2021): 1341–53. http://dx.doi.org/10.1002/dta.3032.

Grafinger, Katharina Elisabeth, Annelies Cannaert, Adam Ametovski, Eric Sparkes, Elizabeth Cairns, Samuel D. Banister, Volker Auwärter, and Christophe P. Stove. "Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB 1 receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay." Drug Testing and Analysis 13, no. 7 (April 14, 2021): 1402–11. http://dx.doi.org/10.1002/dta.3035.

Schram, Jonas, Marc Parrilla, Nick Sleegers, Filip Van Durme, Jorrit Berg, Alexander L. N. Nuijs, and Karolien De Wael. "Electrochemical profiling and liquid chromatography–mass spectrometry characterization of synthetic cathinones: From methodology to detection in forensic samples." Drug Testing and Analysis 13, no. 7 (March 3, 2021): 1282–94. http://dx.doi.org/10.1002/dta.3018.

Keen, Bethany, Adam Cawley, Chris Fouracre, James Pyke, and Shanlin Fu. "Towards an untargeted mass spectrometric approach for improved screening in equine antidoping." Drug Testing and Analysis 13, no. 5 (March 3, 2021): 1001–7. http://dx.doi.org/10.1002/dta.3021.

Yue, Linna, Ping Xiang, Baohua Shen, Duoqi Xu, Fenyun Song, and Hui Yan. "Metabolism of 4F‐MDMB‐BICA in zebrafish by liquid chromatography–high resolution mass spectrometry." Drug Testing and Analysis 13, no. 6 (March 3, 2021): 1223–29. http://dx.doi.org/10.1002/dta.3019.

Nair, Vinod S., Ken Sharpe, Jacob Husk, Geoffrey D. Miller, Peter Van Eenoo, Andre Crouch, and Daniel Eichner. "Evaluation of blood parameters by linear discriminant models for the detection of testosterone administration." Drug Testing and Analysis 13, no. 7 (March 11, 2021): 1270–81. http://dx.doi.org/10.1002/dta.3017.

Kintz, Pascal, Laurie Gheddar, and Jean‐Sébastien Raul. "Simultaneous testing for anabolic steroids in human hair specimens collected from various anatomic locations has several advantages when compared with the standard head hair analysis." Drug Testing and Analysis 13, no. 7 (March 2021): 1445–51. http://dx.doi.org/10.1002/dta.3020.

Kuwayama, Kenji, Hajime Miyaguchi, Tatsuyuki Kanamori, Kenji Tsujikawa, Tadashi Yamamuro, Hiroki Segawa, Yuki Okada, and Yuko T. Iwata. "Development of an improved method to estimate the days of continuous drug ingestion, based on the micro‐segmental hair analysis." Drug Testing and Analysis 13, no. 7 (March 11, 2021): 1295–304. http://dx.doi.org/10.1002/dta.3025.

Høj, Lars Jakobsen, Brian Schou Rasmussen, Petur Weihe Dalsgaard, and Kristian Linnet. "Analysis of seized peptide and protein‐based doping agents using four complimentary methods: Liquid chromatography coupled with time of flight mass spectrometry, liquid chromatography–ultraviolet, Bradford, and immunoassays." Drug Testing and Analysis 13, no. 7 (March 14, 2021): 1457–63. http://dx.doi.org/10.1002/dta.3026.

Cooper, Elliot R., Gillian Hughes, Alexia Kauff, Emma Sutherland, Zoe Ashley, and Alison K. Heather. "A cell‐free bioassay for the detection of androgens." Drug Testing and Analysis 13, no. 5 (March 28, 2021): 903–15. http://dx.doi.org/10.1002/dta.3024.

Manier, Sascha K., Lea Wagmann, Armin A. Weber, and Markus R. Meyer. "Abuse of nutmeg seeds: Detectable by means of liquid chromatography‐mass spectrometry techniques?" Drug Testing and Analysis 13, no. 7 (March 19, 2021): 1440–44. http://dx.doi.org/10.1002/dta.3027.

Ryan, Declan, Dan S. McKemie, Philip H. Kass, Birgit Puschner, and Heather K. Knych. "Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses." Drug Testing and Analysis 13, no. 7 (March 31, 2021): 1305–17. http://dx.doi.org/10.1002/dta.3028.

Bolte, Katarina, Marek Dziadosz, Naomi Kono, Benedikt Vennemann, Michael Klintschar, and Jörg Teske. "Determination of drugs in exhumed liver and brain tissue after over 9 years of burial by liquid chromatography–tandem mass spectrometry—Part 2: Benzodiazepines, opioids, and further drugs." Drug Testing and Analysis 13, no. 7 (April 6, 2021): 1318–30. http://dx.doi.org/10.1002/dta.3029.

Martínez Brito, Dayamín, Patrizia Leogrande, Cristiana Colamonici, Davide Curcio, Francesco Botre, and Xavier Torre. "Arimistane: Degradation product or metabolite of 7‐oxo‐DHEA?" Drug Testing and Analysis 13, no. 7 (April 16, 2021): 1430–39. http://dx.doi.org/10.1002/dta.3036.

Pike, Edward, Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, Jia Lin Luo, Eric Sparkes, Elizabeth A. Cairns, et al. "Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB 1 receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB 1 receptors." Drug Testing and Analysis 13, no. 7 (May 6, 2021): 1383–401. http://dx.doi.org/10.1002/dta.3037.

Haschimi, Belal, Katharina Elisabeth Grafinger, Benedikt Pulver, Evangelia Psychou, Sebastian Halter, Laura M. Huppertz, Folker Westphal, Michael Pütz, and Volker Auwärter. "New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA." Drug Testing and Analysis 13, no. 8 (May 5, 2021): 1499–515. http://dx.doi.org/10.1002/dta.3038.